{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,2]],"date-time":"2026-06-02T09:20:41Z","timestamp":1780392041382,"version":"3.54.1"},"reference-count":49,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,4,16]],"date-time":"2026-04-16T00:00:00Z","timestamp":1776297600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,6,2]],"date-time":"2026-06-02T00:00:00Z","timestamp":1780358400000},"content-version":"vor","delay-in-days":47,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Guangxi Key Laboratory for Preclinical and TranslationalResearch on Bone and Joint Degenerative Diseases, Baise, China.","award":["CN-1215-20014; GX203312"],"award-info":[{"award-number":["CN-1215-20014; GX203312"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Med Imaging"],"DOI":"10.1186\/s12880-026-02347-7","type":"journal-article","created":{"date-parts":[[2026,4,16]],"date-time":"2026-04-16T06:17:33Z","timestamp":1776320253000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Diagnostic performance of artificial intelligence versus conventional imaging for differentiating G2\/G3 from G1 pancreatic neuroendocrine tumors: a systematic review and meta-analysis"],"prefix":"10.1186","volume":"26","author":[{"given":"Zhihao","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinhua","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peng","family":"Lei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qi","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Changhui","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiqi","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,4,16]]},"reference":[{"issue":"7","key":"2347_CR1","doi-asserted-by":"crossref","first-page":"1373","DOI":"10.1007\/s40618-022-01985-2","volume":"46","author":"X Liu","year":"2023","unstructured":"Liu X, Chen B, Chen J, Su Z, Sun S. The incidence, prevalence, and survival analysis of pancreatic neuroendocrine tumors in the United States. J endocrinol invest. 2023;46(7):1373\u201384.","journal-title":"J endocrinol invest"},{"issue":"7","key":"2347_CR2","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1093\/oncolo\/oyac049","volume":"27","author":"MB Sonbol","year":"2022","unstructured":"Sonbol MB, Mazza GL, Mi L, Oliver T, Starr J, Gudmundsdottir H, et al. Survival and Incidence Patterns of Pancreatic Neuroendocrine Tumors Over the Last 2 Decades: A SEER Database Analysis. Oncologist. 2022;27(7):573\u20138.","journal-title":"Oncologist"},{"key":"2347_CR3","doi-asserted-by":"crossref","unstructured":"Das S, Dasari A, Epidemiology. Incidence, and Prevalence of Neuroendocrine Neoplasms: Are There Global Differences? Curr oncol rep. 2021;23(4):43.","DOI":"10.1007\/s11912-021-01029-7"},{"key":"2347_CR4","doi-asserted-by":"crossref","unstructured":"Havasi A, Sur D, Cainap SS, Lungulescu CV, Gavrilas LI, Cainap C, et al. Current and New Challenges in the Management of Pancreatic Neuroendocrine Tumors: The Role of miRNA-Based Approaches as New Reliable Biomarkers. Int J Mol Sci. 2022;23(3).","DOI":"10.3390\/ijms23031109"},{"key":"2347_CR5","doi-asserted-by":"crossref","unstructured":"Maharjan CK, Ear PH, Tran CG, Howe JR, Chandrasekharan C, Quelle DE. Pancreatic Neuroendocrine Tumors: Molecular Mechanisms and Therapeutic Targets. Cancers (Basel). 2021;13(20).","DOI":"10.3390\/cancers13205117"},{"issue":"20","key":"2347_CR6","doi-asserted-by":"crossref","first-page":"2163","DOI":"10.3748\/wjg.v28.i20.2163","volume":"28","author":"YL Li","year":"2022","unstructured":"Li YL, Cheng ZX, Yu FH, Tian C, Tan HY. Advances in medical treatment for pancreatic neuroendocrine neoplasms. World j gastroentero. 2022;28(20):2163\u201375.","journal-title":"World j gastroentero"},{"key":"2347_CR7","doi-asserted-by":"crossref","unstructured":"Marchese U, Gaillard M, Pellat A, Tzedakis S, Abou Ali E, Dohan A, et al. Multimodal Management of Grade 1 and 2 Pancreatic Neuroendocrine Tumors. Cancers (Basel). 2022;14(2).","DOI":"10.3390\/cancers14020433"},{"issue":"3","key":"2347_CR8","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1007\/s00261-018-1803-x","volume":"44","author":"S Ren","year":"2019","unstructured":"Ren S, Chen X, Wang J, Zhao R, Song L, Li H, et al. Differentiation of duodenal gastrointestinal stromal tumors from hypervascular pancreatic neuroendocrine tumors in the pancreatic head using contrast-enhanced computed tomography. Abdom radiol. 2019;44(3):867\u201376.","journal-title":"Abdom radiol"},{"issue":"2","key":"2347_CR9","doi-asserted-by":"crossref","first-page":"e0211566","DOI":"10.1371\/journal.pone.0211566","volume":"14","author":"S Ren","year":"2019","unstructured":"Ren S, Chen X, Wang Z, Zhao R, Wang J, Cui W, et al. Differentiation of hypovascular pancreatic neuroendocrine tumors from pancreatic ductal adenocarcinoma using contrast-enhanced computed tomography. PLoS ONE. 2019;14(2):e0211566.","journal-title":"PLoS ONE"},{"issue":"\u2013","key":"2347_CR10","doi-asserted-by":"crossref","first-page":"109360","DOI":"10.1016\/j.ejrad.2020.109360","volume":"133","author":"S Ren","year":"2020","unstructured":"Ren S, Qian L, Daniels MJ, Duan S, Chen R, Wang Z. Evaluation of contrast-enhanced computed tomography for the differential diagnosis of hypovascular pancreatic neuroendocrine tumors from chronic mass-forming pancreatitis. Eur j radiol. 2020;133(\u2013):109360.","journal-title":"Eur j radiol"},{"issue":"1","key":"2347_CR11","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1007\/s12022-022-09708-2","volume":"33","author":"G Rindi","year":"2022","unstructured":"Rindi G, Mete O, Uccella S, Basturk O, La Rosa S, Brosens LAA, et al. Overview of the 2022 WHO Classification of Neuroendocrine Neoplasms. Endocr pathol. 2022;33(1):115\u201354.","journal-title":"Endocr pathol"},{"key":"2347_CR12","doi-asserted-by":"crossref","unstructured":"Frey S, Miralli\u00e9 E, Le Bras M, Regenet N. What Are the Place and Modalities of Surgical Management for Pancreatic Neuroendocrine Neoplasms? A Narrative Review. Cancers (Basel). 2021;13(23).","DOI":"10.3390\/cancers13235954"},{"issue":"12","key":"2347_CR13","doi-asserted-by":"crossref","first-page":"8250","DOI":"10.1097\/JS9.0000000000002143","volume":"110","author":"K Wei","year":"2024","unstructured":"Wei K, Zheng Q, Cheng L, Li W, Nie\u00dfen A, Uzunoglu FG, et al. Minimally invasive versus open surgery for nonfunctioning pancreatic neuroendocrine tumors: a systematic review and meta-analysis. Int J Surg. 2024;110(12):8250\u20135.","journal-title":"Int J Surg"},{"issue":"7","key":"2347_CR14","doi-asserted-by":"crossref","first-page":"1416","DOI":"10.1016\/j.cgh.2024.03.029","volume":"22","author":"S Hijioka","year":"2024","unstructured":"Hijioka S, Yamashige D, Esaki M, Honda G, Higuchi R, Masui T, et al. Factors Affecting Nonfunctioning Small Pancreatic Neuroendocrine Neoplasms and Proposed New Treatment Strategies. Clin gastroenterol h. 2024;22(7):1416\u201326. e5.","journal-title":"Clin gastroenterol h"},{"key":"2347_CR15","doi-asserted-by":"crossref","unstructured":"Sulciner ML, Clancy TE. Surgical Management of Pancreatic Neuroendocrine Tumors. Cancers (Basel). 2023;15(7).","DOI":"10.3390\/cancers15072006"},{"issue":"6","key":"2347_CR16","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1016\/j.gie.2022.07.014","volume":"96","author":"M Tacelli","year":"2022","unstructured":"Tacelli M, Bina N, Crin\u00f2 SF, Facciorusso A, Celsa C, Vanni AS, et al. Reliability of grading preoperative pancreatic neuroendocrine tumors on EUS specimens: a systematic review with meta-analysis of aggregate and individual data. Gastrointest Endosc. 2022;96(6):898\u2013e90823.","journal-title":"Gastrointest Endosc"},{"issue":"6","key":"2347_CR17","doi-asserted-by":"crossref","first-page":"e1284","DOI":"10.1097\/SLA.0000000000005390","volume":"277","author":"AA Javed","year":"2023","unstructured":"Javed AA, Pulvirenti A, Razi S, Zheng J, Michelakos T, Sekigami Y, et al. Grading Pancreatic Neuroendocrine Tumors Via Endoscopic Ultrasound-guided Fine Needle Aspiration: A Multi-institutional Study. Ann surg. 2023;277(6):e1284\u201390.","journal-title":"Ann surg"},{"key":"2347_CR18","doi-asserted-by":"crossref","unstructured":"Wang SJ, Kidder W, Joseph NM, Le BK, Lindsay S, Moon F, et al. Factors associated with grade progression in pancreatic neuroendocrine tumors. Endocr Relat Cancer. 2025;32(3).","DOI":"10.1530\/ERC-24-0203"},{"issue":"5","key":"2347_CR19","first-page":"188782","volume":"1877","author":"X Lou","year":"2022","unstructured":"Lou X, Qin Y, Xu X, Yu X, Ji S. Spatiotemporal heterogeneity and clinical challenge of pancreatic neuroendocrine tumors. Bba-rev cancer. 2022;1877(5):188782.","journal-title":"Bba-rev cancer"},{"issue":"1","key":"2347_CR20","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1186\/s13244-022-01301-9","volume":"13","author":"HB Zhu","year":"2022","unstructured":"Zhu HB, Nie P, Jiang L, Hu J, Zhang XY, Li XT, et al. Preoperative prediction of lymph node metastasis in nonfunctioning pancreatic neuroendocrine tumors from clinical and MRI features: a multicenter study. Insights Imaging. 2022;13(1):162.","journal-title":"Insights Imaging"},{"issue":"5","key":"2347_CR21","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/j.diii.2017.10.012","volume":"99","author":"F Kulali","year":"2018","unstructured":"Kulali F, Semiz-Oysu A, Demir M, Segmen-Yilmaz M, Bukte Y. Role of diffusion-weighted MR imaging in predicting the grade of nonfunctional pancreatic neuroendocrine tumors. Diagn Interv Imaging. 2018;99(5):301\u20139.","journal-title":"Diagn Interv Imaging"},{"issue":"1","key":"2347_CR22","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1007\/s11604-020-01038-9","volume":"39","author":"K Ohki","year":"2021","unstructured":"Ohki K, Igarashi T, Ashida H, Takenaga S, Shiraishi M, Nozawa Y, et al. Usefulness of texture analysis for grading pancreatic neuroendocrine tumors on contrast-enhanced computed tomography and apparent diffusion coefficient maps. Jpn J Radiol. 2021;39(1):66\u201375.","journal-title":"Jpn J Radiol"},{"issue":"\u2013","key":"2347_CR23","doi-asserted-by":"crossref","first-page":"628408","DOI":"10.3389\/fonc.2021.628408","volume":"11","author":"E Partouche","year":"2021","unstructured":"Partouche E, Yeh R, Eche T, Rozenblum L, Carrere N, Guimbaud R, et al. Updated Trends in Imaging Practices for Pancreatic Neuroendocrine Tumors (PNETs): A Systematic Review and Meta-Analysis to Pave the Way for Standardization in the New Era of Big Data and Artificial Intelligence. Front Oncol. 2021;11(\u2013):628408.","journal-title":"Front Oncol"},{"issue":"12","key":"2347_CR24","doi-asserted-by":"crossref","first-page":"4002","DOI":"10.1007\/s00259-021-05338-8","volume":"48","author":"C Bezzi","year":"2021","unstructured":"Bezzi C, Mapelli P, Presotto L, Neri I, Scifo P, Savi A, et al. Radiomics in pancreatic neuroendocrine tumors: methodological issues and clinical significance. Eur j nucl med mol i. 2021;48(12):4002\u201315.","journal-title":"Eur j nucl med mol i"},{"issue":"1","key":"2347_CR25","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1002\/ueg2.12723","volume":"13","author":"N Podin\u0103","year":"2025","unstructured":"Podin\u0103 N, Gheorghe EC, Constantin A, Cazacu I, Croitoru V, Gheorghe C, et al. Artificial Intelligence in Pancreatic Imaging: A Systematic Review. United Eur Gastroenterol J. 2025;13(1):55\u201377.","journal-title":"United Eur Gastroenterol J"},{"issue":"9","key":"2347_CR26","doi-asserted-by":"crossref","first-page":"16309","DOI":"10.1109\/TNNLS.2025.3558596","volume":"36","author":"C Yuan","year":"2025","unstructured":"Yuan C, Li J, Huang B, Wang M, Cao K, Luo Y, et al. An Efficient Domain Knowledge-Guided Semantic Prediction Framework for Pathological Subtypes on the Basis of Radiological Images With Limited Annotations. IEEE Trans Neural Netw Learn Syst. 2025;36(9):16309\u201323.","journal-title":"IEEE Trans Neural Netw Learn Syst"},{"issue":"1","key":"2347_CR27","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1038\/s41746-025-01970-y","volume":"8","author":"X Yuan","year":"2025","unstructured":"Yuan X, Chen C, Shi Z, Liu W, Zhang X, Yang M, et al. Deep learning CT model for stratified diagnosis of pancreatic cystic neoplasms: multicenter development, validation, and real-world clinical impact. NPJ Digit Med. 2025;8(1):609.","journal-title":"NPJ Digit Med"},{"issue":"\u2013","key":"2347_CR28","doi-asserted-by":"crossref","first-page":"1332387","DOI":"10.3389\/fonc.2024.1332387","volume":"14","author":"Q Yan","year":"2024","unstructured":"Yan Q, Chen Y, Liu C, Shi H, Han M, Wu Z, et al. Predicting histologic grades for pancreatic neuroendocrine tumors by radiologic image-based artificial intelligence: a systematic review and meta-analysis. Front Oncol. 2024;14(\u2013):1332387.","journal-title":"Front Oncol"},{"issue":"\u2013","key":"2347_CR29","doi-asserted-by":"crossref","first-page":"1456557","DOI":"10.3389\/fonc.2025.1456557","volume":"15","author":"E Merola","year":"2025","unstructured":"Merola E, Michielan A, Gabbrielli A, Commentary. Predicting histologic grades for pancreatic neuroendocrine tumors by radiologic image-based artificial intelligence: a systematic review and meta-analysis. Front Oncol. 2025;15(\u2013):1456557.","journal-title":"Front Oncol"},{"issue":"4","key":"2347_CR30","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1001\/jama.2017.19163","volume":"319","author":"MDF McInnes","year":"2018","unstructured":"McInnes MDF, Moher D, Thombs BD, McGrath TA, Bossuyt PM, Clifford T, et al. Preferred Reporting Items for a Systematic Review and Meta-analysis of Diagnostic Test Accuracy Studies: The PRISMA-DTA Statement. JAMA. 2018;319(4):388\u201396.","journal-title":"JAMA"},{"issue":"1","key":"2347_CR31","first-page":"771","volume":"12","author":"C Sihang","year":"2019","unstructured":"Sihang C, Zhengyu J, Huadan X. Evaluation of the histologic grade of pancreatic neuroendocrine tumors using CT texture analysis and perfusion parameters. nt J Clin Exp Med. 2019;12(1):771\u20139.","journal-title":"nt J Clin Exp Med"},{"issue":"10","key":"2347_CR32","doi-asserted-by":"crossref","first-page":"3155","DOI":"10.1007\/s00261-019-02372-x","volume":"45","author":"F Salahshour","year":"2020","unstructured":"Salahshour F, Mehrabinejad MM, Zare Dehnavi A, Alibakhshi A, Dashti H, Ataee MA, et al. Pancreatic neuroendocrine tumors (pNETs): the predictive value of MDCT characteristics in the differentiation of histopathological grades. Abdom Radiol (NY). 2020;45(10):3155\u201362.","journal-title":"Abdom Radiol (NY)"},{"issue":"12","key":"2347_CR33","doi-asserted-by":"crossref","first-page":"6880","DOI":"10.1007\/s00330-019-06176-x","volume":"29","author":"D Gu","year":"2019","unstructured":"Gu D, Hu Y, Ding H, Wei J, Chen K, Liu H, et al. CT radiomics may predict the grade of pancreatic neuroendocrine tumors: a multicenter study. Eur Radiol. 2019;29(12):6880\u201390.","journal-title":"Eur Radiol"},{"issue":"1","key":"2347_CR34","doi-asserted-by":"crossref","first-page":"W1","DOI":"10.7326\/M14-0698","volume":"162","author":"KG Moons","year":"2015","unstructured":"Moons KG, Altman DG, Reitsma JB, Ioannidis JP, Macaskill P, Steyerberg EW, et al. Transparent Reporting of a multivariable prediction model for Individual Prognosis or Diagnosis (TRIPOD): explanation and elaboration. Ann Intern Med. 2015;162(1):W1\u201373.","journal-title":"Ann Intern Med"},{"issue":"8","key":"2347_CR35","doi-asserted-by":"crossref","first-page":"529","DOI":"10.7326\/0003-4819-155-8-201110180-00009","volume":"155","author":"PF Whiting","year":"2011","unstructured":"Whiting PF, Rutjes AW, Westwood ME, Mallett S, Deeks JJ, Reitsma JB, et al. QUADAS-2: a revised tool for the quality assessment of diagnostic accuracy studies. Ann Intern Med. 2011;155(8):529\u201336.","journal-title":"Ann Intern Med"},{"issue":"10","key":"2347_CR36","doi-asserted-by":"crossref","first-page":"4553","DOI":"10.1007\/s00261-025-04865-4","volume":"50","author":"Y Xie","year":"2025","unstructured":"Xie Y, Abaydulla E, Zhang S, Liu H, Hang H, Li Q, et al. Preoperative prediction of pancreatic neuroendocrine tumors grade based on computed tomography, magnetic resonance imaging and endoscopic ultrasonography. Abdom Radiol (NY). 2025;50(10):4553\u201362.","journal-title":"Abdom Radiol (NY)"},{"issue":"1","key":"2347_CR37","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1186\/s12911-025-03193-3","volume":"25","author":"S Mo","year":"2025","unstructured":"Mo S, Zhang Y, Liu N, Jiang R, Yi N, Wang Y, et al. Interpretable deep learning model and nomogram for predicting pathological grading of PNETs based on endoscopic ultrasound. BMC Med Inf Decis Mak. 2025;25(1):360.","journal-title":"BMC Med Inf Decis Mak"},{"issue":"1","key":"2347_CR38","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1186\/s12880-025-01555-x","volume":"25","author":"S Mo","year":"2025","unstructured":"Mo S, Huang C, Wang Y, Qin S. Endoscopic ultrasonography-based intratumoral and peritumoral machine learning ultrasomics model for predicting the pathological grading of pancreatic neuroendocrine tumors. BMC Med Imaging. 2025;25(1):22.","journal-title":"BMC Med Imaging"},{"issue":"3","key":"2347_CR39","first-page":"1994","volume":"34","author":"JY Ye","year":"2024","unstructured":"Ye JY, Fang P, Peng ZP, Huang XT, Xie JZ, Yin XY. A radiomics-based interpretable model to predict the pathological grade of pancreatic neuroendocrine tumors. Eur Radiol. 2024;34(3):1994\u20132005.","journal-title":"Eur Radiol"},{"issue":"14","key":"2347_CR40","doi-asserted-by":"crossref","first-page":"e34344","DOI":"10.1016\/j.heliyon.2024.e34344","volume":"10","author":"S Mo","year":"2024","unstructured":"Mo S, Wang Y, Huang C, Wu W, Qin S. A novel endoscopic ultrasomics-based machine learning model and nomogram to predict the pathological grading of pancreatic neuroendocrine tumors. Heliyon. 2024;10(14):e34344.","journal-title":"Heliyon"},{"issue":"1149","key":"2347_CR41","doi-asserted-by":"crossref","first-page":"20220783","DOI":"10.1259\/bjr.20220783","volume":"96","author":"Y Dong","year":"2023","unstructured":"Dong Y, Yang DH, Tian XF, Lou WH, Wang HZ, Chen S, et al. Pancreatic neuroendocrine tumor: prediction of tumor grades by radiomics models based on ultrasound images. Br J Radiol. 2023;96(1149):20220783.","journal-title":"Br J Radiol"},{"key":"2347_CR42","doi-asserted-by":"crossref","first-page":"109803","DOI":"10.1016\/j.ejrad.2021.109803","volume":"141","author":"A Nakano","year":"2021","unstructured":"Nakano A, Hayano K, Tochigi T, Mashiko T, Masuoka Y, Yamamoto S, et al. Prediction of non-functioning pancreatic neuroendocrine tumor grades with fractal analysis of preoperative contrast-enhanced computed tomography images. Eur J Radiol. 2021;141:109803.","journal-title":"Eur J Radiol"},{"issue":"2","key":"2347_CR43","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1007\/s00261-020-02706-0","volume":"46","author":"Y Bian","year":"2021","unstructured":"Bian Y, Li J, Cao K, Fang X, Jiang H, Ma C, et al. Magnetic resonance imaging radiomic analysis can preoperatively predict G1 and G2\/3 grades in patients with NF-pNETs. Abdom Radiol (NY). 2021;46(2):667\u201380.","journal-title":"Abdom Radiol (NY)"},{"key":"2347_CR44","doi-asserted-by":"crossref","unstructured":"Tixier F, Lopez-Ramirez F, Blanco A, Yasrab M, Javed AA, Chu LC et al. Can CT Image Reconstruction Parameters Impact the Predictive Value of Radiomics Features in Grading Pancreatic Neuroendocrine Neoplasms? Bioengineering. (Basel). 2025;12(1).","DOI":"10.3390\/bioengineering12010080"},{"issue":"2","key":"2347_CR45","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1097\/eus.0000000000000113","volume":"14","author":"S Kiremitci","year":"2025","unstructured":"Kiremitci S, Seven G, Silahtaroglu G, Kochan K, Degirmencioglu Tosun S, Senturk H. The role of artificial intelligence and deep learning in determining the histopathological grade of pancreatic neuroendocrine tumors by using EUS images. Endosc Ultrasound. 2025;14(2):48\u201356.","journal-title":"Endosc Ultrasound"},{"issue":"1","key":"2347_CR46","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.diii.2023.08.002","volume":"105","author":"AA Javed","year":"2024","unstructured":"Javed AA, Zhu Z, Kinny-Koster B, Habib JR, Kawamoto S, Hruban RH, et al. Accurate non-invasive grading of nonfunctional pancreatic neuroendocrine tumors with a CT derived radiomics signature. Diagn Interv Imaging. 2024;105(1):33\u20139.","journal-title":"Diagn Interv Imaging"},{"issue":"6","key":"2347_CR47","doi-asserted-by":"crossref","first-page":"4412","DOI":"10.1007\/s00330-022-09351-9","volume":"33","author":"M Mori","year":"2023","unstructured":"Mori M, Palumbo D, Muffatti F, Partelli S, Mushtaq J, Andreasi V, et al. Prediction of the characteristics of aggressiveness of pancreatic neuroendocrine neoplasms (PanNENs) based on CT radiomic features. Eur Radiol. 2023;33(6):4412\u201321.","journal-title":"Eur Radiol"},{"issue":"5","key":"2347_CR48","doi-asserted-by":"crossref","first-page":"372","DOI":"10.4103\/EUS-D-20-00261","volume":"10","author":"M Tacelli","year":"2021","unstructured":"Tacelli M, Petrone MC, Capurso G, Muffatti F, Andreasi V, Partelli S, et al. Diagnostic accuracy of EUS-FNA in the evaluation of pancreatic neuroendocrine neoplasms grading: Possible clinical impact of misclassification. Endosc Ultrasound. 2021;10(5):372\u201380.","journal-title":"Endosc Ultrasound"},{"issue":"2","key":"2347_CR49","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1097\/MPA.0000000000001212","volume":"48","author":"RL Zong","year":"2019","unstructured":"Zong RL, Geng L, Wang X, Xie D. Diagnostic Performance of Apparent Diffusion Coefficient for Prediction of Grading of Pancreatic Neuroendocrine Tumors: A Systematic Review and Meta-analysis. Pancreas. 2019;48(2):151\u201360.","journal-title":"Pancreas"}],"container-title":["BMC Medical Imaging"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12880-026-02347-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12880-026-02347-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12880-026-02347-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,2]],"date-time":"2026-06-02T08:55:26Z","timestamp":1780390526000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12880-026-02347-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,16]]},"references-count":49,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["2347"],"URL":"https:\/\/doi.org\/10.1186\/s12880-026-02347-7","relation":{},"ISSN":["1471-2342"],"issn-type":[{"value":"1471-2342","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,16]]},"assertion":[{"value":"16 January 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 April 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 April 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"No ethical approval was needed because the data was collected and analyzed from previously reported research where informed consent had been obtained from participants.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"278"}}